Six hundred seriously ill Covid-19 patients have received blood plasma from recuperated patients in a research study scientists hope sheds light on whether the speculative therapy improves health results and yields other helpful data outside the clinical rigor of a conventional medical trial.
The patients are participating in a nationwide expanded-access program licensed in early April by the federal Food and Drug Administration. Expanded gain access to, likewise known as caring use, is typically looked for by patients with dangerous health problems …